EdgarLookup

PharmaCyte Biotech, Inc. — 8-K Filings

102 8-K filings on record

This page lists all 8-K filings submitted to the SEC by PharmaCyte Biotech, Inc. (PMCB), sorted by most recent first. Each row links to the full filing on EdgarLookup. PharmaCyte Biotech, Inc. has filed 102 8-K documents with the SEC since 2001. To view all SEC filings by PharmaCyte Biotech, Inc., see the full filings list.

Overview All Filings Financials Insiders
All 10-K 10-K/A 10-Q 10-Q/A 10KSB 10KSB/A 10QSB 10QSB/A 3 4 424B2 424B3 424B5 425 8-A12B 8-K 8-K/A ARS CERT CORRESP CT ORDER D DEF 14A DEFA14A DFAN14A EFFECT NT 10-K NT 10-Q NTN 10K NTN 10Q PRE 14A PREC14A S-3 S-3/A S-3MEF S-8 S-8 POS SB-2 SB-2/A SC 13D SC 13D/A SC 13G SC 13G/A SC TO-I SC TO-I/A SCHEDULE 13D/A SCHEDULE 13G SCHEDULE 13G/A UPLOAD
Form Description Accession Number Filed Period
8-K FORM 8-K 0001683168-25-008947 Dec 5, 2025 Dec 1, 2025
8-K FORM 8-K 0001683168-25-007871 Oct 31, 2025 Oct 30, 2025
8-K FORM 8-K 0001683168-25-006727 Sep 5, 2025 Sep 2, 2025
8-K CURRENT REPORT 0001683168-25-006274 Aug 18, 2025 Aug 17, 2025
8-K FORM 8-K 0001683168-25-002790 Apr 24, 2025
8-K FORM 8-K 0001683168-25-001236 Feb 26, 2025 Feb 21, 2025
8-K FORM 8-K 0001683168-24-003796 May 23, 2024 May 20, 2024
8-K FORM 8-K 0001683168-24-002881 May 1, 2024 Apr 29, 2024
8-K FORM 8-K 0001683168-23-008446 Nov 24, 2023 Nov 20, 2023
8-K CURRENT REPORT 0001683168-23-008204 Nov 16, 2023 Nov 14, 2023
8-K CURRENT REPORT 0001683168-23-007830 Nov 9, 2023 Nov 5, 2023
8-K FORM 8-K 0001683168-23-006331 Sep 7, 2023 Aug 31, 2023
8-K FORM 8-K 0001683168-23-005293 Aug 4, 2023 Aug 1, 2023
8-K CURRENT REPORT 0001683168-23-004985 Jul 19, 2023 Jul 14, 2023
8-K FORM 8-K 0001683168-23-003169 May 11, 2023 May 9, 2023
8-K FORM 8-K 0001683168-23-000500 Feb 2, 2023 Jan 31, 2023
8-K FORM 8-K 0001683168-22-008705 Dec 30, 2022 Dec 28, 2022
8-K FORM 8-K 0001683168-22-007894 Nov 18, 2022 Nov 14, 2022
8-K FORM 8-K 0001683168-22-007359 Nov 7, 2022 Nov 1, 2022
8-K FORM 8-K 0001683168-22-006911 Oct 14, 2022 Oct 10, 2022
8-K FORM 8-K 0001683168-22-006803 Oct 7, 2022 Oct 6, 2022
8-K CURRENT REPORT 0001683168-22-005782 Aug 16, 2022 Aug 15, 2022
8-K FORM 8-K 0001683168-22-005186 Jul 28, 2022
8-K CURRENT REPORT 0001683168-22-005063 Jul 21, 2022
8-K CURRENT REPORT 0001683168-22-005036 Jul 19, 2022
8-K FORM 8-K 0001683168-22-004874 Jul 11, 2022
8-K CURRENT REPORT 0001683168-22-004361 Jun 15, 2022
8-K FORM 8-K 0001683168-22-004190 Jun 7, 2022 Jun 1, 2022
8-K FORM 8-K 0001683168-22-002580 Apr 13, 2022 Apr 7, 2022
8-K CURRENT REPORT 0001683168-22-002335 Apr 5, 2022 Mar 31, 2022
8-K FORM 8-K 0001683168-22-001550 Mar 9, 2022 Mar 7, 2022
8-K FORM 8-K 0001683168-22-001345 Mar 1, 2022 Feb 24, 2022
8-K FORM 8-K 0001683168-22-001119 Feb 17, 2022 Feb 15, 2022
8-K FORM 8-K 0001683168-21-004199 Sep 10, 2021 Sep 9, 2021
8-K CURRENT REPORT 0001683168-21-003829 Aug 23, 2021 Aug 19, 2021
8-K FORM 8-K 0001683168-21-003431 Aug 12, 2021 Aug 9, 2021
8-K CURRENT REPORT 0001683168-21-003222 Aug 2, 2021
8-K FORM 8-K 0001683168-21-002921 Jul 13, 2021 Jul 9, 2021
8-K FORM 8-K 0001683168-21-002825 Jul 6, 2021 Jun 30, 2021
8-K FORM 8-K 0001683168-21-002661 Jun 22, 2021 Jun 18, 2021
8-K CURRENT REPORT 0001683168-21-002553 Jun 15, 2021 Jun 14, 2021
8-K FORM 8-K 0001683168-21-002359 Jun 4, 2021
8-K FORM 8-K 0001683168-21-001793 May 6, 2021 May 5, 2021
8-K FORM 8-K 0001683168-20-003473 Oct 16, 2020 Oct 14, 2020
8-K FORM 8-K 0001683168-20-001127 Apr 8, 2020 Apr 6, 2020
8-K FORM 8-K 0001683168-20-000204 Jan 21, 2020
8-K FORM 8-K 0001683168-19-003515 Nov 8, 2019 Nov 7, 2019
8-K FORM 8-K 0001683168-19-003157 Oct 3, 2019 Sep 20, 2019
8-K FORM 8-K 0001683168-19-002754 Aug 26, 2019 Aug 23, 2019
8-K FORM 8-K 0001683168-18-001309 May 15, 2018 May 14, 2018